Welcome

 

VelaLabs is a world -wide acting, GMP-certified and GCLP-compliant contract laboratory that offers in-depth analytical characterization services for proteins including biopharmaceuticals, biosimilars, biologics and Peptides.

Combining a focused, customer - orientated approach, a highly motivated team and a broad expertise in analytical development and quality control, VelaLabs is dedicated to support customer's needs from research activities to clinical phases up to product commercialization and market release.

News

September 2018. VelaLabs is now registered at the FDA.
Read more
September 2018. VelaLabs is now a listed CRO of MSD.
Read more
August 2018. VelaLabs expertise covers a variety of biomolecules and is now presenting some basic information for more than 20 blockbuster drugs in fact sheets.
Read more
During summer 2018, VelaLabs has further expanded analytical capabilities for excipients in biopharmaceutical formulations.
Read more
In March 2018, the leadership of VelaLabs in the field of lectin microarray analysis was honored with a review article published in the journal Medical Research Archives.
Read more
In January 2018, MSc. MA Jennifer Mayrhofer was appointed as CPO for VelaLabs.
Read more
During 2017, VelaLabs invested 1,000,000 € into its instrumental park and can now also offer structural characterization and determination of extractables and leachables.
Read more